Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05401838 · ClinicalTrials.gov registry record · NA
The Group Risk Reduction Intervention Therapy (GRRIT) Project
A NA study of Depression and Anxiety, sponsored by University of North Carolina, Charlotte.
- Active
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT05401838: Active NA study of Depression and Anxiety, sponsored by University of North Carolina, Charlotte.
NCT05401838 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by University of North Carolina, Charlotte. The registered enrollment target is 141 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05401838, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by University of North Carolina, Charlotte.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will evaluate a group format adaptation of Brief Cognitive-Behavioral Therapy for Suicide (i.e., G-BCBT) on suicide ideation (Aim 1), ability to use coping strategies (Aim 2), and overall mental health (exploratory analysis). The combination of tailored means safety counseling and training in evidence-based emotion regulation and cognitive flexibility skills delivered via a 12-session group therapy treatment will decrease service members' overall suicide risk. The group format will provide opportunities to learn and practice skills, thereby enhancing self-efficacy. G-BCBT outcomes are expected to be no worse than Dialectical Behavior Therapy (DBT) group skills training, an existing gold standard intervention that is twice the length of time as G-BCBT.
Primary Outcome
Suicidal ideation will be measured with the Beck Scale for Suicide Ideation (BSSI). The BSSI contains 19 self-report items assessing of suicidal ideation. With a score range of 0 to 38, higher scores reflect worse ideation. The BSSI demonstrates strong reliability and associations with suicide measures when used with military personnel.
Conditions Studied
Interventions
- BEHAVIORAL Group Brief Cognitive-Behavioral Therapy (G-BCBT)
- BEHAVIORAL Dialectical Behavior Therapy (DBT) Skills Group
Study Locations (1)
Virginia
- Naval Medical Center Portsmouth - Portsmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT05401838 still lists
NCT05401838 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (82% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Group Brief Cognitive-Behavioral Therapy (G-BCBT) is the first listed.
NCT05401838 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05401838 about?
NCT05401838 is a clinical study titled "The Group Risk Reduction Intervention Therapy (GRRIT) Project". Investigators will evaluate a group format adaptation of Brief Cognitive-Behavioral Therapy for Suicide (i.e., G-BCBT) on suicide ideation (Aim 1), ability to use coping strategies (Aim 2), and overall mental health (exploratory analysis). The combination of tailored means safety counseling and trai...
What is the current status of trial NCT05401838?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2023-06-01. Estimated completion is 2026-02-28.
What conditions does trial NCT05401838 study?
This clinical trial studies the following conditions: Depression, Anxiety, PTSD, Suicidal Ideation, Suicide, Attempted.
What interventions are being tested in trial NCT05401838?
The interventions under investigation include: Group Brief Cognitive-Behavioral Therapy (G-BCBT) (BEHAVIORAL), Dialectical Behavior Therapy (DBT) Skills Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05401838?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05401838 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05401838's enrollment target sits among peer trials
141 270th of 679 higher than 409 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy